Deciphering the Nanometabolomics Paradigm: Understanding the Role of Pathophysiology and Biomarkers in Predicting Oral Cancer

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

Article  PubMed  Google Scholar 

Scully C, Porter S (2001) Oral cancer. West J Med 174:348–351

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gutschner T, Diederichs S (2012) The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9:703–719

Article  CAS  PubMed  PubMed Central  Google Scholar 

IARC (2023). Oral cancer prevention. IARC Handb Cancer Prev. 19:1–358. Available from: https://publications.iarc.fr/617.

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2024. Available from: https://gco.iarc.who.int/today,accessed [08 May 2024]

Sufianov A, Begliarzade S, Kudriashov V, Beilerli A, Ilyasova T, Liang Y et al (2022) The role of circular RNAs in the pathophysiology of oral squamous cell carcinoma. Noncoding RNA Res 8:109–114

Article  PubMed  PubMed Central  Google Scholar 

Kansara S, Sivam S. Premalignant Lesions of the Oral Mucosa. [Updated 2023 May 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572155/

Kar A, Wreesmann VB, Shwetha V, Thakur S, Rao VUS, Arakeri G et al (2020) Improvement of oral cancer screening quality and reach: the promise of artificial intelligence. J Oral Pathol Med 49:727–730

Article  PubMed  Google Scholar 

Lai YH, Liu H, Chiang WF, Chen TW, Chu LJ, Yu JS et al (2018) MiR-31-5p-ACOX1 axis enhances tumorigenic fitness in oral squamous cell carcinoma via the promigratory prostaglandin E2. Theranostics 8:486–504

Article  CAS  PubMed  PubMed Central  Google Scholar 

Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR et al (2021) Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO collaborating centre for oral cancer. Oral Dis 27:1862–1880

Article  PubMed  Google Scholar 

Axéll T, Pindborg JJ, Smith CJ, van der Waal I (1996) Oral white lesions with special reference to precancerous and tobacco—related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21 1994. international collaborative group on oral white lesions. J Oral Pathol Med 25:49–54

Article  PubMed  Google Scholar 

Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42:561–568

Article  CAS  PubMed  Google Scholar 

Chen X, Yu D (2019) Metabolomics study of oral cancers. Metabolomics 15:22

Article  PubMed  Google Scholar 

Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabolomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189

Article  CAS  PubMed  Google Scholar 

Fiehn O (2001) Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genomics 2:155–168

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chetwynd AJ, Abdul-Sada A, Hill EM (2015) Solid-phase extraction and nanoflow liquid chromatography-nanoelectrospray ionization mass spectrometry for improved global urine metabolomics. Anal Chem 87:1158–1165

Article  CAS  PubMed  Google Scholar 

Gowda GA, Djukovic D (2014) Overview of mass spectrometry-based metabolomics: opportunities and challenges. Methods Mol Biol 1198:3–12

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aichler M, Walch A (2015) MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice. Lab Invest 95:422–431

Article  CAS  PubMed  Google Scholar 

Beckwith-Hall BM, Thompson NA, Nicholson JK, Lindon JC, Holmes E (2003) A metabonomic investigation of hepatotoxicity using diffusion-edited 1H NMR spectroscopy of blood serum. Analyst 128:814–818

Article  CAS  PubMed  Google Scholar 

Kumari P, Debta P, Dixit A (2022) Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer. Front Pharmacol 13:825266

Article  CAS  PubMed  PubMed Central  Google Scholar 

Radaic A, Kamarajan P, Cho A, Wang S, Hung GC, Najarzadegan F et al (2023) Biological biomarkers of oral cancer. Periodontol 2000. https://doi.org/10.1111/prd.12542

Article  PubMed  Google Scholar 

Wang Q, Gao P, Wang X, Duan Y (2014) The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics. Sci Rep 4:6802

Article  PubMed  PubMed Central  Google Scholar 

Shinmura K, Igarashi H, Kato H, Kawanishi Y, Inoue Y, Nakamura S et al (2014) CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung. Dis Markers 2014:619273

Article  PubMed  PubMed Central  Google Scholar 

Kademani D, Lewis JT, Lamb DH, Rallis DJ, Harrington JR (2009) Angiogenesis and CD34 expression as a predictor of recurrence in oral squamous cell carcinoma. J Oral Maxillofac Surg 67:1800–1805

Article  PubMed  Google Scholar 

Nagata M, Noman AA, Suzuki K, Kurita H, Ohnishi M, Ohyama T et al (2013) ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma. BMC Cancer 13:410

Article  PubMed  PubMed Central  Google Scholar 

Akervall J, Nandalur S, Zhang J, Qian CN, Goldstein N, Gyllerup P et al (2014) A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck. Eur J Cancer 50:570–581

Article  CAS  PubMed  Google Scholar 

Chong ZX, Yeap SK, Ho WY (2020) Roles of circulating microRNA(s) in human breast cancer. Arch Biochem Biophys 695:108583

Article  CAS  PubMed  Google Scholar 

Zhu M, Nie G, Meng H, Xia T, Nel A, Zhao Y (2013) Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc Chem Res 46:622–631

Article  CAS  PubMed  Google Scholar 

Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7:653–664

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biju V (2014) Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem Soc Rev 43:744–764

Article  CAS  PubMed  Google Scholar 

Combes GF, Vučković AM, Perić Bakulić M, Antoine R, Bonačić-Koutecky V, Trajković K (2021) Nanotechnology in tumor biomarker detection: the potential of liganded nanoclusters as nonlinear optical contrast agents for molecular diagnostics of cancer. Cancers (Basel) 13:4206

Article  CAS  PubMed  Google Scholar 

Joudeh N, Linke D (2022) Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnology 20:262

Article  PubMed  PubMed Central  Google Scholar 

Scida K, Stege PW, Haby G, Messina GA, García CD (2011) Recent applications of carbon-based nanomaterials in analytical chemistry: critical review. Anal Chim Acta 691:6–17

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif